glp 1 for cardiovascular The effects of GLP-1 receptor agonists beyond obesity and type 2 diabetes: An anti-atherosclerotic action JCI - Cardioprotective GLP-1 metabolite

I-square (I 2 ) statistics and the Q test were performed to assess the impact of study heterogeneity on the results of the meta-analysis

The Notch signaling pathway inhibitor Dapt alleviates autism-like behavior, autophagy and dendritic spine density abnormalities in a valproic acid-induced animal model of autism

Fiar, Z

However, the emerging paradigm recognizes microglia as exquisitely plastic cells capable of adopting diverse functional states, including neuroprotective phenotypes that may actually counteract disease progression under certain conditions [120, 123, 456]

GLP-1 MEDICATIONS There are currently two classes of GLP-1 receptor agonists available for weight loss: semaglutide and tirzepatide

As a result, they accumulate, leading to chronic illness